Photo of Michelle M. Ovanesian

Michelle Ovanesian is an associate in the Litigation Department, where she focuses on intellectual property and life sciences. Michelle has worked on a range of matters in federal district courts, including serving on the successful trial team in the Amgen Inc. v. Sanofi remand jury trial in the District of Delaware.

In addition to intellectual property and life sciences, Michelle's practice has encompassed a variety of other legal matters, including privacy and cybersecurity, and bankruptcy litigation. Most recently, Michelle was part of the litigation team that represented the Financial Oversight and Management Board in the Commonwealth of Puerto Rico’s bankruptcy proceedings.

Michelle maintains an active pro bono practice, with a focus on immigration law and civil rights. As part of her pro bono work, Michelle has filed an amicus brief in state court supporting the constitutionality of executive orders.

The life sciences sector is in its “golden era” of innovation with the convergence of disciplines
—including genetics, immunology, cell biology, and artificial intelligence—changing the speed, efficiency, and cost at which innovation occurs.  

With this era has come a fierce market for talent, resulting in the frequent movement of

On December 1, 2023, in Global Discovery Biosciences Corp. v. Harrington, et al., No. 2022-1132, a Vice Chancellor of the Delaware Court of Chancery ruled on the balance of a motion to dismiss brought back in June 2023 by two former CEOs-Dr. Harrington and Mr. Nuñez (together, “Defendants”)-who were